Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer.

Hitij NT, Kern I, Sadikov A, Knez L, Stanič K, Zwitter M, Cufer T.

Clin Lung Cancer. 2017 May;18(3):e187-e196. doi: 10.1016/j.cllc.2016.11.021. Epub 2016 Dec 2.

PMID:
28089159
2.

Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis.

Verstovsek S, Manshouri T, Pilling D, Bueso-Ramos CE, Newberry KJ, Prijic S, Knez L, Bozinovic K, Harris DM, Spaeth EL, Post SM, Multani AS, Rampal RK, Ahn J, Levine RL, Creighton CJ, Kantarjian HM, Estrov Z.

J Exp Med. 2016 Aug 22;213(9):1723-40. doi: 10.1084/jem.20160283. Epub 2016 Aug 1.

3.

Update on systemic therapy of advanced non-small-cell lung cancer.

Cufer T, Knez L.

Expert Rev Anticancer Ther. 2014 Oct;14(10):1189-203. doi: 10.1586/14737140.2014.940327. Epub 2014 Aug 7. Review.

PMID:
25098682
4.

Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions.

Rezonja R, Knez L, Cufer T, Mrhar A.

Radiol Oncol. 2013 Mar;47(1):1-13. doi: 10.2478/raon-2013-0008. Epub 2013 Feb 1.

5.

Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting.

Lekic M, Kovac V, Triller N, Knez L, Sadikov A, Cufer T.

Radiol Oncol. 2012 Mar;46(1):54-9. doi: 10.2478/v10019-012-0007-1. Epub 2012 Jan 2.

6.

Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy.

Sodja E, Knez L, Kern I, Ovčariček T, Sadikov A, Cufer T.

Eur J Cancer. 2012 Dec;48(18):3378-85. doi: 10.1016/j.ejca.2012.06.011. Epub 2012 Jul 12.

PMID:
22795264
7.

Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.

Knez L, Košnik M, Ovčariček T, Sadikov A, Sodja E, Kern I, Cufer T.

J Cancer Res Clin Oncol. 2012 Sep;138(9):1551-60. doi: 10.1007/s00432-012-1231-1. Epub 2012 Apr 29.

PMID:
22543673
8.

Estimation of renal function in lung cancer patients.

Trobec K, Knez L, Meško Brguljan P, Cufer T, Lainščak M.

Lung Cancer. 2012 Jun;76(3):397-402. doi: 10.1016/j.lungcan.2011.11.016. Epub 2011 Dec 15.

PMID:
22177534
9.

The need for medication reconciliation: a cross-sectional observational study in adult patients.

Knez L, Suskovic S, Rezonja R, Laaksonen R, Mrhar A.

Respir Med. 2011 Oct;105 Suppl 1:S60-6. doi: 10.1016/S0954-6111(11)70013-0.

10.

Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor.

Manshouri T, Estrov Z, Quintás-Cardama A, Burger J, Zhang Y, Livun A, Knez L, Harris D, Creighton CJ, Kantarjian HM, Verstovsek S.

Cancer Res. 2011 Jun 1;71(11):3831-40. doi: 10.1158/0008-5472.CAN-10-4002. Epub 2011 Apr 21.

11.

Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: a systematic review.

Knez L, Sodja E, Kern I, Košnik M, Cufer T.

Lung Cancer. 2011 Jun;72(3):271-9. doi: 10.1016/j.lungcan.2011.02.014. Epub 2011 Mar 26. Review.

PMID:
21440950
12.

Evaluation of clinical interventions made by pharmacists in chemotherapy preparation.

Knez L, Laaksonen R, Duggan C.

Radiol Oncol. 2010 Dec;44(4):249-56. doi: 10.2478/v10019-010-0040-x. Epub 2010 Sep 22.

Supplemental Content

Support Center